Thermo Fisher Scientific Inc. plans to pay about $13.6 billion for Life Technologies Corp. in a deal that will position the scientific instrument maker to benefit from the expected growth of personalized medicine, which uses genetic analysis to tailor treatments to patients.  

 

Life Technologies was formed in November 2008 through the combination of Invitrogen Corp. and Applied Biosystems Inc. Read the full Wisconsin State Journal story here.